CUSTOMER SUPPORT CUSTOMER SUPPORT +91-9999-696-045

fund search

Individually analyse each scheme and narrow your options further Every minute detail you need to know about scheme of your choice from asset holdings, best and worst performance and fund returns to competitor analysis; is available in the Fund card.
Using this report card, you can gather vital information regarding the future health of the scheme by analysing the top 10 companies and sectors it invests in. You can also track the fund management’s track record and analyse the philosophy behind scheme’s holdings. All the parameters in the fund card are extremely important and can go a long way in helping you decide which scheme to invest your money.

NAV As on Jun-01-2020

Mirae Asset Healthcare Fund(G)-Direct Plan

Top 10 Holdings
Company
(%)
Sun Pharmaceutical Industries Limited
12.23
Dr. Reddy's Laboratories Limited
9.29
Divi's Laboratories Limited
8.44
Biocon Limited
6.14
Lupin Limited
5.66
IPCA Laboratories Limited
5.65
Aurobindo Pharma Limited
5.34
Tri Party Repo
5.31
Ajanta Pharma Limited
4.35
Cipla Limited
4.28
Top 10 Sectors
Sectors
(%)
Pharmaceuticals & Drugs
74.94
Hospital & Healthcare Services
6.42
Chemicals
5.64
Miscellaneous
2.90
Diversified
2.01
Insurance
1.71
Finance - Others
1.50
Asset Allocation
Market Cap Allocation
  Scheme Benchmark ()
Large-Cap 60.67 NA
Mid-Cap 32.04 NA
Small-Cap 7.29 NA

Best and Worst Performance and Ratios

Best Performance in a year
Period Fund (%) Benchmark (%)
Year 29/05/19
to 29/05/20
37.4518.81
Worst Performance in a year
Period Fund (%) Benchmark (%)
Year 28/08/18
to 28/08/19
-6.75-19.01
Ratios
Standard Deviation[%] 27.17
Sharpe Ratio [%] 0.46
Turnover Ratio [%] 0.40
Modified Duration
YTM
Riskometer
high risk

Investors understand that their principal will be at high risk

Fund Details
Category
Sector Funds
Inception Date (Regular Plan)
02-Jul-18
Inception Date (Direct Plan)
02-Jul-18
Expense Ratio (Direct Plan) %
0.78
Expense Ratio (Regular Plan) %
2.50
Investing Style
Large Growth
Fund Manager
Vrijesh Kasera
Scheme Benchmark
S&P BSE HEALTH CARE - TRI
AUM (Rs. in Cr.)
526.28
Fund Objective

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. The Scheme does not guarantee or assure any returns.

Growth Chart of the Scheme Versus Benchmark (SIP value Rs10,000)
Mirae Asset Healthcare Fund(G)-Direct Plan S&P BSE Health Care - TRI

Performance Comparison with similar Schemes and Benchmark